Amira A. Albawri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Amira A. Albawri has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Abdelaziz A. Awad
Faculty of Medicine, Al-Azhar University, Cairo, Egypt
2 shared publications - Ahmed Gad
Hennepin County Medical Centre, Minneapolis, USA
2 shared publications - Basma M. El-Khalifa
Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt
2 shared publications - Doaa A. Elmarzouky
Faculty of General Surgery and Medicine, Zagazig University, Zagazig, Egypt
2 shared publications - Yara M. Harash
Faculty of Medicine, Hama University, Hama, Syria
2 shared publications - Youssef Narouz
Faculty of Medicine, Ain Shams University, Cairo, Egypt
2 shared publications
Latest Publications
- Open Access
- 27 March 2026
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1)
Efficacy of swab-based RUT in detecting H. pylori infection: a systematic review and meta-analysis
Introduction: Helicobacter pylori ( H. pylori ) is a gram-negative bacterium found in the gastric mucosa of humans. In this systematic review, our objective was to assess the diagnostic performance of the swab technique in detecting H. pylori infection. Methods: We followed the PRISMA guidelines and searched four databases for studies comparing the efficacy of swabs or sweeping techniques in detecting H. pylori infection. Outcomes were diagnostic accuracy measures, such as sensitivity and specificity. Results: Four studies with 658 patients were included. Compared to conventional diagnosis methods, overall sensitivity was 0.93, with a 95% CI (0.85; 0.97). A confusion matrix was used to summarize the previously mentioned results. Gastric swabs reported a high sensitivity of 93.7%, with a high number of true positives = 285. However, test specificity is moderate (74.1%). Conclusion: These results indicate that gastric swab-based RUT may be helpful as an initial diagnostic test, specifically if a biopsy is difficult. More studies with large sample sizes are needed to confirm these findings.
- 27 March 2026
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1)
Open AccessEfficacy of swab-based RUT in detecting H. pylori infection: a systematic review and meta-analysis
Introduction: Helicobacter pylori ( H. pylori ) is a gram-negative bacterium found in the gastric mucosa of humans. In this systematic review, our objective was to assess the diagnostic performance of the swab technique in detecting H. pylori infection. Methods: We followed the PRISMA guidelines and searched four databases for studies comparing the efficacy of swabs or sweeping techniques in detecting H. pylori infection. Outcomes were diagnostic accuracy measures, such as sensitivity and specificity. Results: Four studies with 658 patients were included. Compared to conventional diagnosis methods, overall sensitivity was 0.93, with a 95% CI (0.85; 0.97). A confusion matrix was used to summarize the previously mentioned results. Gastric swabs reported a high sensitivity of 93.7%, with a high number of true positives = 285. However, test specificity is moderate (74.1%). Conclusion: These results indicate that gastric swab-based RUT may be helpful as an initial diagnostic test, specifically if a biopsy is difficult. More studies with large sample sizes are needed to confirm these findings.
- Open Access
- 3 February 2026
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 71 (7) , 1-36
Propofol Versus Remimazolam in Gastrointestinal Endoscopy: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background Propofol is the most commonly used intravenous anesthetic for endoscopic surgery, although it comes with various adverse effects. Research indicates that Remimazolam, which is considered a safe general anesthetic, is being increasingly adopted as an alternative to propofol in clinical settings. Our meta-analysis sought to evaluate whether the rate of adverse reactions associated with Remimazolam in gastrointestinal endoscopic procedures is acceptable, and whether its surgical success rate is at least comparable to that of propofol. Methods Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, we searched five electronic databases (PubMed, Scopus, Cochrane Library, Embase, and Web of Science) to identify eligible studies published up to January 2025. Using R version R.4.4, we reported outcomes as risk ratios (RRs) or mean differences (MDs) and confidence intervals (CIs). A P-value of ≤ 0.05 is considered statistically significant. Results Our meta-analysis included 37 studies encompassing 8533 patients. The results, analyzed using a random effects model, demonstrated no statistically significant difference in induction time between the two sedative groups, with an overall MD of 0.11 min (95% [- 0.10; 0.31], p = 0.2977). Patients in the Remimazolam group experienced longer total sedation times than those receiving Propofol, with an MD of 1.84 min (95% CI [0.61; 3.07], p = 0.0033). The pooled analysis indicated low heterogeneity (I2 = 4.2%). There was no statistically significant difference between the two sedatives in procedure time, with an MD of 0.16 (95% CI: [−0.13; 0.45], p = 0.2689). The pooled analysis displayed moderate heterogeneity (I2 = 43.5%, p = 0.0052). Conclusion Remimazolam has demonstrated safety, showing a reduced incidence of hypotension, bradycardia, respiratory depression, and hypoxemia compared to propofol. However, efficacy outcomes including the induction time and total procedure time were comparable between the two groups. However, the results were heterogeneous, which could be due to variability in the perfumed procedures, co-analgesics or dosing.
- 3 February 2026
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 71 (7) , 1-36
Open AccessPropofol Versus Remimazolam in Gastrointestinal Endoscopy: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background Propofol is the most commonly used intravenous anesthetic for endoscopic surgery, although it comes with various adverse effects. Research indicates that Remimazolam, which is considered a safe general anesthetic, is being increasingly adopted as an alternative to propofol in clinical settings. Our meta-analysis sought to evaluate whether the rate of adverse reactions associated with Remimazolam in gastrointestinal endoscopic procedures is acceptable, and whether its surgical success rate is at least comparable to that of propofol. Methods Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, we searched five electronic databases (PubMed, Scopus, Cochrane Library, Embase, and Web of Science) to identify eligible studies published up to January 2025. Using R version R.4.4, we reported outcomes as risk ratios (RRs) or mean differences (MDs) and confidence intervals (CIs). A P-value of ≤ 0.05 is considered statistically significant. Results Our meta-analysis included 37 studies encompassing 8533 patients. The results, analyzed using a random effects model, demonstrated no statistically significant difference in induction time between the two sedative groups, with an overall MD of 0.11 min (95% [- 0.10; 0.31], p = 0.2977). Patients in the Remimazolam group experienced longer total sedation times than those receiving Propofol, with an MD of 1.84 min (95% CI [0.61; 3.07], p = 0.0033). The pooled analysis indicated low heterogeneity (I2 = 4.2%). There was no statistically significant difference between the two sedatives in procedure time, with an MD of 0.16 (95% CI: [−0.13; 0.45], p = 0.2689). The pooled analysis displayed moderate heterogeneity (I2 = 43.5%, p = 0.0052). Conclusion Remimazolam has demonstrated safety, showing a reduced incidence of hypotension, bradycardia, respiratory depression, and hypoxemia compared to propofol. However, efficacy outcomes including the induction time and total procedure time were comparable between the two groups. However, the results were heterogeneous, which could be due to variability in the perfumed procedures, co-analgesics or dosing.